IRIS
PARISI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 300
EU - Europa 184
AS - Asia 168
AF - Africa 15
OC - Oceania 2
SA - Sud America 2
Totale 671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 297
CN - Cina 85
IT - Italia 65
SG - Singapore 61
IE - Irlanda 33
FR - Francia 31
DE - Germania 19
CI - Costa d'Avorio 14
IN - India 11
FI - Finlandia 8
SE - Svezia 7
GB - Regno Unito 5
KR - Corea 5
NL - Olanda 5
BG - Bulgaria 3
AT - Austria 2
AU - Australia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CA - Canada 1
CH - Svizzera 1
CY - Cipro 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
JM - Giamaica 1
JP - Giappone 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 671
Salva come PNG Salva come JPEG
Città #
Boardman 90
Singapore 46
Ashburn 39
Dublin 31
Shenzhen 22
Chandler 17
Fairfield 15
Abidjan 14
Zhengzhou 12
Ancona 11
Rome 10
Seattle 10
Jacksonville 8
Shanghai 8
Helsinki 7
Houston 7
Washington 7
Ann Arbor 6
Des Moines 6
Los Angeles 6
Dallas 5
Lawrence 5
Princeton 5
Saint Louis 5
Seoul 5
Guangzhou 4
Nuremberg 4
London 3
Ningbo 3
San Diego 3
Somma Vesuviana 3
Woodbridge 3
Amsterdam 2
Bellante 2
Chennai 2
Dresden 2
Giulianova 2
Macerata 2
Milan 2
Modena 2
Mumbai 2
New Delhi 2
New York 2
San Mateo 2
Sant'Egidio alla Vibrata 2
Santa Clara 2
Stuttgart 2
Tolentino 2
Vienna 2
Visakhapatnam 2
Wuhan 2
Xi'an 2
Yiwu 2
Acton 1
Amandola 1
Ankang 1
Beijing 1
Bologna 1
Cambridge 1
Casoria 1
Changsha 1
Chengdu 1
Chiswick 1
Chongqing 1
Dortmund 1
Florence 1
Fort Worth 1
Haikou 1
Hong Kong 1
Huzhou 1
Jinhua 1
La Paz 1
Lima 1
Lincoln 1
Luoyang 1
Mariglianella 1
Matelica 1
Montreal 1
Nicosia 1
North Charleston 1
Norwalk 1
Panama City 1
Porto Sant'Elpidio 1
Pune 1
Ranchi 1
Sanmenxia 1
Schnaittach 1
St Petersburg 1
Taipei 1
Tel Aviv 1
Tokyo 1
Turin 1
Wilmington 1
Zurich 1
Totale 503
Salva come PNG Salva come JPEG
Nome #
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 66
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 62
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 37
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 31
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 29
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 24
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies 22
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis 22
Evaluation of prognostic factors for survival in transverse colon cancer 22
Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report 21
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 21
Multimodality treatment in metastatic gastric cancer: From past to next future 20
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study 20
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 20
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 19
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 19
The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer 18
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 18
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry 18
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma 17
What is known about theragnostic strategies in colorectal cancer 17
Post-induction Strategies in Metastatic Colorectal Cancer Patients Treated With First-Line Anti-EGFR-Based Treatment: A Systematic Review and Meta-Analysis 17
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status 16
How to best exploit immunotherapeutics in advanced gastric cancer: Between biomarkers and novel cell-based approaches 14
null 14
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers 13
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 13
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study 12
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 9
SEX-RELATED DIFFERENCES IN EFFICACY AND SAFETY OF IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS OF LANDMARK PHASE III TRIALS AND VALIDATION IN ROUTINE CLINICAL PRACTICE 9
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: Preliminary report of the FAMI-L1 study 8
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study 8
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 8
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study 7
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 7
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 6
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 6
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice 6
Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer 6
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen 6
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study 6
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy 5
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 5
Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study 5
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 4
Looking for a place for dose-dense TMZ regimens in GBM patients: An experience with MGMT exploratory evaluation 4
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 4
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference 3
Where are we with treatment options after first line in small cell lung cancer?-Report of two opposite cases treated with CAPTEM regimen and possible perspectives 3
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 3
Into the storms: Organising oncological home care services during natural disasters and global pandemics 2
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer 2
null 1
Totale 775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.640
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 1 1 4
2020/202137 2 4 4 1 9 0 0 5 2 4 2 4
2021/202231 0 2 0 0 0 2 1 1 13 1 6 5
2022/202371 5 3 4 10 0 11 0 2 18 7 10 1
2023/2024257 16 3 13 19 18 27 2 13 1 71 25 49
2024/2025373 151 77 46 12 39 48 0 0 0 0 0 0
Totale 775